Rainier Clinical Research Center listed on incransom leak site

• Ransomware group: incransom
• Country: United States
• Sector: Healthcare
• Announcement date: February 23, 2026

Rainier Clinical Research Center targeted by incransom

The Rainier Clinical Research Center has been listed on the leak site of the ransomware group known as incransom. This listing follows claims made by the threat actors regarding a data breach involving the organization.

The incransom group published an announcement on February 23, 2026, claiming to have obtained data belonging to the Rainier Clinical Research Center. According to the group's statement, they intend to publish all the information they have acquired next week. At this stage, it is important to note that the group has not provided any screenshots to support their claims. Consequently, there is no visual evidence available to verify the scope or the specific content of the alleged breach.

Details of the alleged breach

Regarding the specifics of the incident, the group has not shared any information concerning the nature of the allegedly leaked data. Furthermore, no screenshots have been made available to the public to illustrate the contents of the stolen files. Because no specific data types or file counts were provided in the announcement, the exact extent of the compromise remains unverified.

Data characteristics

• The listing names no specific data types.

Analysis of the threat and potential impact

Given the known tactics of the incransom group, which often involve double-extortion, there is a significant risk that the organization's sensitive clinical research data could be exposed. This type of attack involves stealing sensitive information and threatening to leak it to pressure the victim into paying a ransom, creating a dual threat of operational disruption and data exposure.

For an organization operating within the healthcare sector, such a breach can lead to serious complications. The exposure of sensitive information may create compliance issues regarding patient privacy and data security regulations, such as HIPAA. Furthermore, the publication of the organization's data could potentially lead to identity theft or targeted phishing attacks against individuals participating in research studies.

Beyond the immediate privacy concerns, the potential leaks concerning the organization's trade secrets and medical device studies may result in long-term operational and reputational losses. While public information regarding the incransom group remains limited, the potential consequences for a clinical research entity are multifaceted, ranging from regulatory scrutiny to the loss of intellectual property and trust from study participants.

Organizations in this sector typically face heightened risks due to the high value of medical research and patient data. To mitigate such risks, defensive strategies often include implementing robust encryption for data at rest and in transit, maintaining strict access controls, and conducting regular security audits. However, the specific details of this incident remain unconfirmed due to the lack of evidence provided by the threat actor.